Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 123Precursor Cell Lymphoblastic Leukemia-Lymphoma 105Myelodysplastic Syndromes 101Lymphoma, Non-Hodgkin 94Leukemia, Lymphocytic, Chronic, B-Cell 94Hodgkin Disease 88Multiple Myeloma 82Leukemia 73Lymphoma, Mantle-Cell 63Lymphoma, Follicular 62Lymphoma 62Lymphoma, Large B-Cell, Diffuse 59Myeloproliferative Disorders 55Lymphoma, B-Cell, Marginal Zone 55Leukemia, Myelogenous, Chronic, BCR-ABL Positive 54Burkitt Lymphoma 50Leukemia, Myelomonocytic, Chronic 48Congenital Abnormalities 46Leukemia, Myeloid, Chronic-Phase 45Lymphoma, Large-Cell, Immunoblastic 42Leukemia, Myeloid, Accelerated Phase 39Anemia, Refractory, with Excess of Blasts 36Hematologic Neoplasms 35Waldenstrom Macroglobulinemia 34Primary Myelofibrosis 34Graft vs Host Disease 34Blast Crisis 31Neoplasms, Plasma Cell 30Recurrence 28Dendritic Cell Sarcoma, Interdigitating 28

Interventions

thymoglobulin 1Prone Position 1Mycophenolic Acid 1Cyclosporine 1Antilymphocyte Serum 1Acetazolamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neural Tube Defects × Mycophenolic Acid × Clear all
NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡